CS logo
small CS logo
Grupo Cooperativo de Hemopatías Malignas

Huixquilucan, Estado De México, Mexico

About Grupo Cooperativo de Hemopatías Malignas


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at Grupo Cooperativo de Hemopatías Malignas


During the past decade, Grupo Cooperativo de Hemopatías Malignas conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Grupo Cooperativo de Hemopatías Malignas


According to Clinical.Site data, the most researched conditions in "Grupo Cooperativo de Hemopatías Malignas" are "Acute Myeloid Leukemia" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)" (1 trials), "COVID-19" (1 trials) and "Chronic Myeloid Leukaemia Recurrent" (1 trials). Many other conditions were trialed in "Grupo Cooperativo de Hemopatías Malignas" in a lesser frequency.

Clinical Trials Intervention Types at Grupo Cooperativo de Hemopatías Malignas


Most popular intervention types in "Grupo Cooperativo de Hemopatías Malignas" are "Drug" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-azacitidine" (1 trials), "Daratumumab Only Product in Parenteral Dose Form" (1 trials), "Ibrutinib" (1 trials), "Myeloid mutations measurement" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Grupo Cooperativo de Hemopatías Malignas


The vast majority of trials in "Grupo Cooperativo de Hemopatías Malignas" are 5 trials for "All" genders.

Clinical Trials Status at Grupo Cooperativo de Hemopatías Malignas


Currently, there are NaN active trials in "Grupo Cooperativo de Hemopatías Malignas". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Grupo Cooperativo de Hemopatías Malignas, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Grupo Cooperativo de Hemopatías Malignas, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status